Literature DB >> 6177991

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli.

G M Scott, R J Phillpotts, J Wallace, C L Gauci, J Greiner, D A Tyrrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6177991     DOI： 10.1016/s0140-6736(82)91031-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

1.  Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.

Authors:  A Zerial; G H Werner; R J Phillpotts; J S Willmann; P G Higgins; D A Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

Review 2.  Viral infection in cystic fibrosis.

Authors:  J Stroobant
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

3.  Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.

Authors:  B M Farr; J M Gwaltney; K F Adams; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

4.  Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon.

Authors:  A S Monto; J K Albrecht; S A Schwartz
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

5.  Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.

Authors:  F G Hayden; D L Kaiser; J K Albrecht
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

6.  Interferon in acute viral infections.

Authors:  S Levin
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

7.  Farr sighted.

Authors:  T Richards
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28

8.  Antibody to human leucocyte interferon may enhance the frequency of rhinovirus isolation.

Authors:  R J Phillpotts
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

9.  Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers.

Authors:  P G Higgins; R J Phillpotts; G M Scott; J Wallace; L L Bernhardt; D A Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

Review 10.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.